As Big Pharma Downsizes, a Major Loss of Brain Power

Maybe the 15 women chatting over coffee at the Wegmans supermarket cafe in Malvern should start their own pharmaceutical firm. They have the brain power, if not the capital. A scientist who spent 19 years in drug development sat a few tables away from a coordinator of clinical trials. A few managed pharmaceutical finances, and one administered a $2.7 billion global research and development budget. One handled drug pricing and another edited marketing materials. The former human resources person squeezed in next to the woman who once worked in supply logistics.

MORE ON THIS TOPIC